주식/증권 ➡️ 중립 Praxis signals two FDA decisions in ~six months, targets ~$10B ulixacaltamide peak sales while building a ~300-person field force Seeking Alpha - Market News 2026/08/07 12:27:55 3회 원문 기사 보기